Leaderboards/Heterotopic Ossification and Related Conditions

Heterotopic Ossification and Related Conditions

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Yongkuk Park
Brigham and Women's Hospital
2
Johanna Nunez
Organogenesis (United States)
3
Sean S. Keating
The University of Queensland
4
Yeon-Suk Yang
University of Massachusetts Chan Medical School
5
Neda Vishlaghi
Organogenesis (United States)
6
Madysen Hunter
Organogenesis (United States)
7
Senem Aykul
Regeneron (United States)
8
Yunkai Tang
Shanghai Jiao Tong University
9
Claudia Del Toro Runzer
German Center for Neurodegenerative Diseases
10
Guanzhi Li
Southern Medical University

Papers

1
Intestine-Settled Electrospun Short-Fibers Modulate Epithelial Transport Proteins to Reduce Purine and Glucose Uptake
Advanced Fiber Materials|2024
17 cit.
2
Publication in Wound Repair and Regeneration (2024) [5 citations, W4402892434]
Wound Repair and Regeneration|2024
5 cit.
3
Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases
Molecular Therapy|2025
4 cit.
4
Progress in oral biomaterials for the treatment of metabolic bone diseases
Progress in Materials Science|2025
2 cit.
5
Early detection of aberrant cell fate and repair using circulating progenitor cells in patients with heterotopic ossification
Nature Communications|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ingvar Jarle Vaage
Oslo University Hospital
2
Hana M. Odeh
University of Pennsylvania
3
Yanwei Wu
Ocean University of China
4
Yong‐Jie Zhang
Jacksonville College
5
Sarah Hatsell
Regeneron (United States)
6
Qiaoli Li
Guangxi Medical University
7
Chun‐Yuan Chen
Central South University
8
Jungwoo Lee
Seoul National University
9
Weiguo Zou
Center for Excellence in Molecular Cell Science
10
Hui Lin
Nanchang University

Papers

1
Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis
Science Advances|2022
211 cit.
2
Discovery and Application of Postnatal Nucleus Pulposus Progenitors Essential for Intervertebral Disc Homeostasis and Degeneration
Advanced Science|2022
83 cit.
3
TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes
Nature Communications|2022
65 cit.
4
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Journal of Clinical Investigation|2022
64 cit.
5
Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance
Cell Communication and Signaling|2024
54 cit.
6
The RNA-binding protein Musashi2 governs osteoblast-adipocyte lineage commitment by suppressing PPARγ signaling
Bone Research|2022
52 cit.
7
Cu‐Catalyzed Coupling Reactions of Sulfonamides with (Hetero)Aryl Chlorides/Bromides
Angewandte Chemie International Edition|2022
41 cit.
8
Precipitate coarsening and mechanical properties in 6082 aluminium alloy during long-term thermal exposure
Journal of Alloys and Compounds|2022
39 cit.
9
ENPP1 variants in patients with GACI and PXE expand the clinical and genetic heterogeneity of heritable disorders of ectopic calcification
PLoS Genetics|2022
32 cit.
10
Functional and analytical recapitulation of osteoclast biology on demineralized bone paper
Nature Communications|2023
29 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Frederick S. Kaplan
University of Pennsylvania
2
José Luís Millán
Discovery Institute
3
Eileen M. Shore
Fisher & Paykel Healthcare (New Zealand)
4
Lee H. Riley
Johns Hopkins University
5
Kohei Miyazono
The University of Tokyo
6
Benjamin Lévi
Organogenesis (United States)
7
Caroline S. Hill
The Francis Crick Institute
8
Michael P. Whyte
Shriners Hospitals for Children - St. Louis
9
Peter ten Dijke
Leiden University Medical Center
10
Michael R. Galarneau
Naval Health Research Center

Papers

1
Ectopic Ossification Following Total Hip Replacement
Journal of Bone and Joint Surgery|1973
2.8k cit.
2
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nature|1997
1.8k cit.
3
SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
Molecular Pharmacology|2002
1.7k cit.
4
The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF
Cell|1995
1.3k cit.
5
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva
Nature Genetics|2006
1.2k cit.
6
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
Journal of Bone and Mineral Research|2010
1.1k cit.
7
Modulation of microRNA processing by p53
Nature|2009
1.1k cit.
8
Bone Formation and Inflammation in Cardiac Valves
Circulation|2001
1k cit.
9
Smad6 inhibits signalling by the TGF-β superfamily
Nature|1997
1k cit.
10
Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter
Journal of Biological Chemistry|2002
882 cit.

Reagents for Heterotopic Ossification and Related Conditions

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

p53 (7F5) Rabbit Monoclonal Antibody (Biotinylated)

#4667$556
View Evidence →
Cell Signaling TechnologyEvidence 66

TAZ (V386) Antibody

#4883$317
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-SMAD1 (Ser463/465)/ SMAD5 (Ser463/465)/ SMAD9 (Ser465/467) (D5B10) Rabbit Monoclonal Antibody

#13820$169,996
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

RING1B (D22F2) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 6 papers
#20948$865
View Evidence →
Cell Signaling TechnologyEvidence 65

SMAD1 Antibody

Cited in 5 papers
#9743$368
View Evidence →
Cell Signaling Technology

LysoTracker® Green DND-26

Cited in 5 papers
#8783$268
View Evidence →